$P2587Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH)$

P2587Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH)

Kramer, T.; Orlova, K.; Gerhardt, F.; Dumitrescu, D.; Ten Freyhaus, H.; Baldus, S.; Rosenkranz, S.

期刊名称European Heart Journal
作者Kramer, T.; Orlova, K.; Gerhardt, F.; Dumitrescu, D.; Ten Freyhaus, H.; Baldus, S.; Rosenkranz, S.
卷第38卷
印刷ISSN0195-668X
电子ISSN1522-9645
文件大小505.62KB
发表时间2017-08-01
DOI10.1093/eurheartj/ehx502.P2587

发现好书期刊，享受阅读乐趣

P2587Therapeutic effects of phosphodiesterase 5 inhibitors in patients with heart failure with preserved ejection fraction (HFpEF) and combined post- and pre-capillary pulmonary hypertension (Cpc-PH)